Champlain Investment Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Champlain Investment Partners's VCYT Position: Q1 2026 in Review
Champlain Investment Partners reduced its Veracyte (VCYT) stake by 59% in Q1 2026, selling an estimated $15.1M and leaving 281,923 shares worth $9.08M. The position accounts for 0.12% of the portfolio, ranked #126.
Champlain Investment Partners first reported a position in VCYT in Q1 2021 and has held it in 19 quarters since. The position peaked at $86.2M in Q3 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Champlain Investment Partners held 281,923 shares of Veracyte worth $9.08M as of Q1 2026.
- Champlain Investment Partners sold 406,859 Veracyte shares in Q1 2026, an estimated $15.1M.
- Veracyte made up 0.12% of Champlain Investment Partners's portfolio in Q1 2026, its #126 holding.
- Champlain Investment Partners first reported a position in Veracyte in Q1 2021 and has held it in 19 quarters since.
- Champlain Investment Partners's Veracyte position peaked at $86.2M in Q3 2024.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.